Holding(s) in Company
13 Oktober 2008 - 12:38PM
UK Regulatory
RNS Number : 6912F
Curidium Medica PLC
13 October 2008
Form TR-1 with annex. FSA Version 2.1 updated April 2007
TR-1: Notifications of Major Interests in Shares
1. Identity of the issuer or the underlying issuer Curidium Medica plc
of existing shares to which voting rights are
attached:
2. Reason for notification (yes/no)
An acquisition or disposal of voting rights Yes
An acquisition or disposal of financial instruments which may result in No
the acquisition of shares already issued to which voting rights are
attached
An event changing the breakdown of voting rights No
Other (please specify): No
3. Full name of person(s) Gartmore Investment Limited
subject to notification
obligation:
4. Full name of shareholder(s) See attached schedule
(if different from 3):
5. Date of transaction (and 30 September 2008
date on which the threshold is
crossed or reached if
different):
6. Date on which issuer 1 October 2008
notified:
7. Threshold(s) that is/are 20%
crossed or reached:
8: Notified Details
A: Voting rights attached to shares
Class/type of shares Situation previous to the triggering Resulting situation after the triggering transaction
If possible use ISIN transaction
code
Number of shares Number of voting Number of shares Number of voting Percentage of voting
rights rights rights
Direct Indirect Direct Indirect
GB00B2PNRV79 3,753,499 3,753,499 3,805,999 3,805,999 20.09%
B: Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument Expiration date Exercise/ conversion No. of voting rights Percentage of voting
period/date that may be acquired rights
(if the instrument
exercised/converted)
N/A N/A N/A N/A N/A
Total (A+B)
Number of voting rights Percentage of voting rights
3,805,999 20.09%
9. Chain of controlled undertakings through which the voting rights and /or
the financial instruments are effectively held, if applicable:
N/A
Proxy Voting:
10. Name of proxy holder: N/A
11. Number of voting rights proxy holder will cease to hold: N/A
12. Date on which proxy holder will cease to hold voting rights: N/A
13. Additional information: All shares are held indirectly.
14 Contact name: Robert Smith, Curidium Medica Plc
15. Contact telephone name: 020 7383 5345
For notes on how to complete form TR-1 please see the FSA website.
Schedule
Fund managing co No. of shares held Percentage of issued UK Registered owner Fund Beneficial Owner
(Ord GBP 0.03) share capital
Gartmore Fund Managers Limited 845,556 4.46% HSBC Global Custody 56690 Gartmore Fund
Nominee UK Ltd Managers Ltd a/c
Gartmore UK & Irish
Smaller Companies
Gartmore Investment Limited 500,000 2.64% BNY GIL CLT a/c NOMS LST Gartmore Smaller
Ltd a/c LST Companies Trust PLC
Gartmore Investment Limited 2,460,443 12.98% Vidacos Nominees Ltd Volant The Alphagen
a/c 2303 Volantis Fund
Limited
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLMJBMTMMJBBRP
Curidium Medica (LSE:CUR)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
Curidium Medica (LSE:CUR)
Historical Stock Chart
Von Jun 2023 bis Jun 2024
Echtzeit-Nachrichten über Curidium Medica (Londoner Börse): 0 Nachrichtenartikel
Weitere Curidium Medica Plc News-Artikel